MAPK14 as a key gene for regulating inflammatory response and macrophage M1 polarization induced by ferroptotic

Lin Zhou1,2,3,4,5, Yingdong Zhong6, Chaowei Li7

  • 1Subcenter for Stem Cell Clinical Translation, First Affiliated Hospital of Gannan Medical University, Ganzhou, 341000, Jiangxi, People's Republic of China.

Inflammation
|March 5, 2024
PubMed

Insights

This study identifies six key ferroptosis-related diagnostic genes (FRDGs) for psoriasis. Targeting MAPK14 in skin cells shows promise for reducing inflammation and improving psoriasis treatment.

Area of Science:

  • Dermatology
  • Immunology
  • Molecular Biology

Background:

  • Psoriasis is a chronic inflammatory skin disease with immune dysregulation.
  • Ferroptosis, an iron-dependent cell death, is a newly recognized factor in disease pathogenesis.
  • Understanding novel molecular mechanisms is crucial for effective psoriasis management.

Purpose of the Study:

  • To identify novel ferroptosis-related diagnostic genes (FRDGs) for psoriasis.
  • To investigate the role of these genes in disease mechanisms and immune responses.
  • To explore potential therapeutic targets, particularly MAPK14 signaling.

Main Methods:

  • Bioinformatic analyses including WGCNA, LASSO, and Random Forest on psoriasis datasets (GSE30999, GSE41662, GSE14905).
  • Gene Set Enrichment Analysis (GSEA) for pathway analysis.
  • In vivo and in vitro experiments including gene knockdown and drug inhibition (SW203580).

Main Results:

  • Six FRDGs (PPARD, MAPK14, PARP9, POR, CDCA3, PDK4) were identified, forming a highly accurate diagnostic model (AUC=0.994).
  • These genes are involved in psoriasis-related pathways and correlate with immune cell infiltration and oxidative stress.
  • Inhibition of MAPK14 in keratinocytes reduced ferroptosis, inflammation, and modulated macrophage polarization.

Conclusions:

  • Novel FRDGs offer potential diagnostic biomarkers for psoriasis.
  • MAPK14 signaling in keratinocytes is a key regulator of ferroptosis and inflammation in psoriasis.
  • Targeting MAPK14 presents a promising therapeutic strategy for psoriasis management.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
2.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K